30 Days of US Healthcare: The Inflation Reduction Act
About this video
This 30 Days of US Healthcare sketch stages a pharmaceutical executive’s horror at the Inflation Reduction Act allowing Medicare to negotiate some drug prices. Flanary portrays the company as dependent on charging whatever it wants, treating government oversight as a novel illness the executive is experiencing for the first time. The boss predicts the industry will simply raise prices on drugs outside the negotiation and let allied benefit managers and insurers pass costs along, concluding that healthcare corporations, in this telling, always protect shareholder profit.
Key takeaways
- Flanary portrays Medicare price negotiation as a first encounter with oversight for drug companies
- The sketch argues lost revenue on negotiated drugs would be recovered on uncontrolled ones
- His point is that patients’ savings depend on how the whole pricing chain reacts
- The act is characterized by the characters as a half measure against entrenched profit motives
Episode details: published September 24, 2023 · 162.2K views · 1:49 long. Summary written by Self Growth Videos from the episode itself. Everything described is Dr. Glaucomflecken’s (Will Flanary, MD) satire and commentary on the US medical system, attributed to him as satire — his sketches are comedy, not documentation, and this is not medical advice.
← Previous: 30 Days of US Healthcare: DIR Fees · Next: 30 Days of US Healthcare: Family Medicine Negotiates with UHC →
All Dr. Glaucomflecken videos · Dr. Glaucomflecken profile · Dr. Glaucomflecken (official site)
